Skip to content
When should an alternative agent to vancomycin be considered for MRSA infections? episode artwork

Nov 21, 2010

When should an alternative agent to vancomycin be considered for MRSA infections?

from Let's Talk MRSA: 20 Frequently Asked Questions Hosted by Vemco MedEd

In this Episode, Dr. Scott T. Micek from Barnes-Jewish Hospital in St. Louis, Missouri provides insights on when an alternative agent to vancomycin should be considered for MRSA infections.

Episode details come from the podcast's RSS feed.

Embed this episode

Ready to play

When should an alternative agent to vancomycin be considered for MRSA infections?

No transcript yet.

Requests help us decide what to transcribe next.

Frequently asked questions

When was this Let's Talk MRSA: 20 Frequently Asked Questions episode published?

This episode was published on November 21, 2010.

Can I download this Let's Talk MRSA: 20 Frequently Asked Questions episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.